Hy-Tech Engineers vs Symbiotec Pharmalab vs Skyways Air IPO: Which Will List At Higher Premium?

As reported by NDTV Profit - Latest

Hy-Tech Engineers IPO leads listing day gains with an 81% upside, ahead of Skyways Air Services (28.6%) and Symbiotec Pharmalab (24.3%), per latest GMP.

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on NDTV Profit - Latest ↗

Market Samachar is a news aggregator. This article was originally published by NDTV Profit - Latest. Tap the button above to read the full story on their site.

INDIAN India bonds slump on Fed rate hike bets, benchmark trades at discount Markets-Economic Times
INDIAN MSCI rejig: Laurus, Lenskart among 4 stocks set for $1.5 bn inflows Share Market Today
INDIAN Priority Jewels IPO Day 2: Issue subscribed 17.03x so far. GMP hints 23% listing gain. Should you subscribe? mint - markets
INDIAN Lumino Industries IPO Day 3: Issue subscribed 33.27x so far. GMP hints 74% listing pop. Apply or not? mint - markets
GLOBAL Shares ease in Asia as oil climbs, yields stay high - Reuters Reuters
COMPANIES Transformers and Rectifiers shares rally 8% after receiving order worth up to Rs 100-500 crore from MEIL Stocks-Markets-Economic Times
GLOBAL Harbor Human Capital Factor US Small Cap ETF Q2 2026 Commentary (HAPS) seekingalpha.com
GLOBAL Octave and MAIRE collaborate on the application of AI across engineering and construction workflows financialpost.com

Hy-Tech Engineers vs Symbiotec Pharmalab vs Skyways Air IPO: Which Will List At Higher Premium?

More from Market Samachar